Medical Equipment

Projected Growth of the Global Point-of-Care (POC) Coagulation Testing Market to Reach $1.47 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the point-of-care (poc) coagulation testing market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Point-of-Care (POC) Coagulation Testing Market By The End Of 2029?

The point-of-care (poc) coagulation testing market size has demonstrated robust growth over recent years. It is anticipated to expand from $1.18 billion in 2024 to $1.25 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.4%. This historical growth can be linked to several factors, including an increase in patient demand, the rising popularity of point-of-care testing, the strong dependability of coagulation status determined by PT tests, the adoption of automation and integration with electronic health records (EHRs), and the growing prevalence of cardiovascular diseases and blood disorders.

The point-of-care (poc) coagulation testing market is projected to experience consistent expansion over the upcoming years. It is forecast to reach $1.47 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.2%. This anticipated growth is driven by several factors, including broader applications in healthcare, increased demand in homecare environments, a rise in chronic blood disorders, patient need for swift and precise testing, and the general increase in point-of-care testing. Key developments anticipated during this period encompass technological innovations, significant demand from developed nations, expanding healthcare applications, the influence of COVID-19, and the advent of multiplexing POC diagnostics.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp

Which Business Drivers Are Underpinning The Growth Of The Point-of-Care (POC) Coagulation Testing Market?

The increasing prevalence of cardiovascular diseases is projected to fuel expansion in the point-of-care (POC) coagulation testing market. Cardiovascular diseases (CVDs) encompass various disorders of the heart and blood vessels, including conditions such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing is vital for managing these conditions as it offers immediate insights into coagulation status, enabling prompt intervention decisions and reducing the risk of bleeding complications after cardiac surgery. For instance, an October 2022 report from the World Heart Federation indicated a projected rise in CVD-related mortality, with deaths anticipated to increase from approximately 18.9 million in 2020 to over 22.2 million by 2030, and further to 32.3 million by 2050. Consequently, the rising incidence of cardiovascular diseases is a significant driver for the point-of-care (POC) coagulation testing market.

What Are The Principal Segment Types In The Point-of-Care (POC) Coagulation Testing Market?

The point-of-care (poc) coagulation testingmarket covered in this report is segmented –

1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology

2) By Distribution Channel: Direct Tenders, Retail

3) By End-User: Hospitals, Clinics, Home care

Subsegments:

1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection

2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection

3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection

How Are Industry Trends Steering The Expansion Of The Point-of-Care (POC) Coagulation Testing Market?

Leading companies in the point-of-care (POC) coagulation testing market are concentrating on strategic collaborations to achieve a competitive advantage. A strategic collaboration involves a formal agreement between two or more parties working together towards specific, predetermined, and mutually beneficial goals. For instance, in January 2023, Jana care, a US-based company that develops biomarker assays for its proprietary digital health platform, partnered with Roche Diagnostics, a Switzerland-based company known for developing diagnostic tests, instruments, and digital solutions that aim to transform healthcare. This collaboration intends to develop and distribute a point-of-care blood testing platform designed for screening chronic kidney disease and heart failure. This innovative platform will empower patients to perform blood tests at home, with clinicians remotely reviewing the results.

Which Companies Are Contributing Significantly To The Point-of-Care (POC) Coagulation Testing Market Growth?

Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

Which Region Offers The Most Opportunity For Point-of-Care (POC) Coagulation Testing Market Expansion?

North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp

Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Market 2025, By The Business Research Company

Immunochemistry Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunochemistry-diagnostic-devices-and-equipment-global-market-report

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Implantable Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795